Jack L Wyszomierski sold $4.4M of Exelixis (EXEL)

Executed Feb 18, disclosed Feb 20, 2 days later.

Value, as filed

$4.4M

99,574 sh × $44.01

Executed

Feb 18

the trade date, as filed

Disclosed

Feb 20

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

JW Jack L Wyszomierski Director profile →

Jack L Wyszomierski (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Exelixis, Inc. (EXEL). The largest single filing was $4.4M of EXEL (99,574 sh × $44.01, as filed), executed Feb 18.

The name

EXEL Exelixis, Inc. EXEL · Healthcare · 53 filings in 24 months ticker →

Healthcare · Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat c…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jack L Wyszomierski in EXEL

EXELSALE Exelixis, Inc. $198K
3,925 sh × $50.55
Exec Jun 1
Filed Jun 3 · 5:30 PM ET EXELSALE Exelixis, Inc. $325K
7,535 sh × $43.09
Exec Jun 3 2025
Filed Jun 4 2025 · 5:30 PM ET EXELSALE Exelixis, Inc. $331K
8,768 sh × $37.80
Exec Feb 28 2025
Filed Feb 28 2025 · 5:30 PM ET